Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer.

Prabhavalkar KS, Poovanpallil NB, Bhatt LK.

Front Pharmacol. 2015 Oct 23;6:242. doi: 10.3389/fphar.2015.00242. eCollection 2015. Review.

2.

A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Grados MA, Atkins EB, Kovacikova GI, McVicar E.

Psychol Res Behav Manag. 2015 Apr 28;8:115-31. doi: 10.2147/PRBM.S58601. eCollection 2015. Review.

3.

Preclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extract.

Shin IJ, Son SU, Park H, Kim Y, Park SH, Swanberg K, Shin JY, Ha SK, Cho Y, Bang SY, Lew JH, Cho SH, Maeng S.

PLoS One. 2014 Feb 10;9(2):e88617. doi: 10.1371/journal.pone.0088617. eCollection 2014.

4.

Novel glutamatergic drugs for the treatment of mood disorders.

Lapidus KA, Soleimani L, Murrough JW.

Neuropsychiatr Dis Treat. 2013;9:1101-12. doi: 10.2147/NDT.S36689. Epub 2013 Aug 7.

5.

A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.

Tränkner A, Sander C, Schönknecht P.

Neuropsychiatr Dis Treat. 2013;9:101-11. doi: 10.2147/NDT.S37126. Epub 2013 Jan 18.

6.

Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.

Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR.

Bipolar Disord. 2012 Nov;14(7):780-9. doi: 10.1111/bdi.12013.

7.

A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.

Brown ES, Sunderajan P, Hu LT, Sowell SM, Carmody TJ.

Neuropsychopharmacology. 2012 Oct;37(11):2347-54. doi: 10.1038/npp.2012.90. Epub 2012 Jun 6.

8.

Use of a relapse monitoring board: an independent assessment for determining relapse in clinical trials for bipolar disorder.

Turner N, Macfadden W, Anand R, Khanna S, Rapaport MH, Haskins JT, Turkoz I, Alphs L.

Innov Clin Neurosci. 2011 Oct;8(10):19-24.

9.

Management of Bipolar II Disorder.

Wong MM.

Indian J Psychol Med. 2011 Jan;33(1):18-28. doi: 10.4103/0253-7176.85391.

10.

A review of bipolar disorder in adults.

Hilty DM, Leamon MH, Lim RF, Kelly RH, Hales RE.

Psychiatry (Edgmont). 2006 Sep;3(9):43-55.

11.

Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder.

Pavuluri MN, Passarotti AM, Harral EM, Sweeney JA.

J Clin Psychiatry. 2010 Nov;71(11):1526-34. doi: 10.4088/JCP.09m05504yel. Epub 2010 Aug 24.

12.

Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.

Swartz HA, Thase ME.

J Clin Psychiatry. 2011 Mar;72(3):356-66. doi: 10.4088/JCP.09r05192gre. Epub 2010 Aug 10. Review.

13.

Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Brunoni AR, Tadini L, Fregni F.

PLoS One. 2010 Mar 3;5(3):e9479. doi: 10.1371/journal.pone.0009479. Review.

14.

Bipolar disorder.

Geddes JR, Briess D.

BMJ Clin Evid. 2007 Aug 1;2007. pii: 1014. Review.

15.

The role of lamotrigine in the management of bipolar disorder.

Ng F, Hallam K, Lucas N, Berk M.

Neuropsychiatr Dis Treat. 2007 Aug;3(4):463-74.

16.

Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder.

Pavuluri MN, Henry DB, Moss M, Mohammed T, Carbray JA, Sweeney JA.

J Child Adolesc Psychopharmacol. 2009 Feb;19(1):75-82. doi: 10.1089/cap.2008.0107.

17.

Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder.

Nassir Ghaemi S, Shirzadi AA, Filkowski M.

Medscape J Med. 2008;10(9):211. Epub 2008 Sep 10.

18.

Bipolar depression: trial-based insights to guide patient care.

Kemp DE, Muzina DJ, McIntyre RS, Calabrese JR.

Dialogues Clin Neurosci. 2008;10(2):181-92. Review.

19.

Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study.

Muzina DJ, Momah C, Eudicone JM, Pikalov A, McQuade RD, Marcus RN, Sanchez R, Carlson BX.

Int J Clin Pract. 2008 May;62(5):679-87. doi: 10.1111/j.1742-1241.2008.01735.x. Epub 2008 Mar 25.

20.

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.

Suppes T, Marangell LB, Bernstein IH, Kelly DI, Fischer EG, Zboyan HA, Snow DE, Martinez M, Al Jurdi R, Shivakumar G, Sureddi S, Gonzalez R.

J Affect Disord. 2008 Dec;111(2-3):334-43. doi: 10.1016/j.jad.2008.02.004. Epub 2008 Mar 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk